Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
暂无分享,去创建一个
J. Shih | C. Liam | Shun Lu | T. Jang | Yong-feng Yu | S. Lu | Yong-feng Yu | Yong-feng Yu
暂无分享,去创建一个
J. Shih | C. Liam | Shun Lu | T. Jang | Yong-feng Yu | S. Lu | Yong-feng Yu | Yong-feng Yu